Position in AMGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$10,501
-$9,084 QoQ
Shares Held
29
-57.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3,079
of 3,139 holders
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Altshuler Shaham Ltd holds $141,070 across 8 Drug Manufacturers - General names. AMGN ranks #6 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
126 | $32,000 | |
| 2 | LLY |
ELI LILLY & Co
|
19,232 | $29,986 | |
| 3 | ABBV |
AbbVie Inc.
|
97 | $24,409 | |
| 4 | MRK |
Merck & Co., Inc.
|
135 | $17,347 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
102 | $12,886 | |
| 6 | AMGN |
Amgen Inc
This page
|
29 | $10,501 | |
| 7 | PFE |
Pfizer Inc
|
311 | $7,488 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
112 | $6,453 |
All Filings in AMGN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,501 | 29 | Shares | Defined | 2026-08-12 | |
| 2023-12-31 | $19,585 | 68 | Shares | Defined | 2024-02-07 | |
| 2023-06-30 | $36,633 | 165 | Shares | Defined | 2023-07-24 | |
| 2023-03-31 | $43,998 | 182 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $192,515 | 733 | Shares | Defined | 2023-05-09 | |
| 2022-09-30 | $231,711 | 1,028 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $257,898 | 1,060 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $89,231 | 369 | Shares | Defined | 2022-05-16 | |
| 2020-09-30 | $26,178 | 103 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $27,831 | 118 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $21,488 | 106 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||